|
|
|
|
| LEADER |
02579nam a22002775i 4500 |
| 001 |
000286714 |
| 005 |
20211124103125.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2000 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781592590797
|
| 024 |
7 |
|
|a 10.1385/1592590799
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Hepatocellular Carcinoma :
|b Methods and Protocols /
|c edited by Nagy A. Habib.
|
| 250 |
|
|
|a 1st ed. 2000.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2000.
|
| 300 |
|
|
|a XIII, 302 p. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in Molecular Medicine,
|v 45
|
| 505 |
0 |
|
|a The Clinical Problem -- Hepatocellular Carcinoma -- Medical Management of Hepatocellular Carcinoma -- HCC Carcinogenesis -- Possible Involvement of the NS3 Protein of Hepatitis C Virus in Hepatocarcinogenesis -- Abrogation of p53-Induced Apoptosis by the Hepatitis B Virus X Gene -- Hepatocellular Carcinoma -- Molecular and Biological Characteristics -- The Impact of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) -- Mutation of p53 Tumor Suppressor Gene in Hepatocellular Carcinoma -- Diagnostic Markers in Hepatocellular Carcinoma Using Immunohistochemical Techniques -- Assessing Matrix Metalloproteinase Expression and Activity in Hepatocellular Carcinomas -- Isolation of Novel Markers for Hepatocellular Carcinoma by a Subtraction-Enhanced Display Technique -- Measurement of Protein Expression of p53, p21WAF1, and Rb in Patients with Surgically Treated Hepatocellular Carcinoma by Using Catalyzed Signal-Amplification System -- HCC Gene Therapy -- Gene Therapy Vectors Harboring AFP Regulatory Sequences -- Advantages and Disadvantages of Multiple Different Methods of Adenoviral Vector Construction -- Electron Microscopic Assessment of Adenovirus-Mediated Transfer -- p53 Plasmid Preparation and Techniques for Analysis of Gene Transfer and Expression -- Antisense IGF-I for Hepatocellular Carcinoma -- Novel Effective Tumor Vaccines for Hepatocellular Carcinoma -- Immunoglobulin Fusion Proteins as a Tool for Evaluation of T-Cell Costimulatory Molecules -- Adenovirus-Mediated Drug-Sensitivity Gene Therapy for Hepatocellular Carcinoma -- Clinical Protocol for P53 Gene Therapy for Liver Tumors -- Clinical Protocol for p53 Gene Therapy for Liver Tumors.
|
| 650 |
|
0 |
|a Oncology .
|
| 650 |
1 |
4 |
|a Oncology.
|
| 700 |
1 |
|
|a Habib, Nagy A.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|